Mark A. Goldsmith - Sep 1, 2023 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Signature
/s/ Jack Anders, as attorney-in fact for Mark A. Goldsmith
Stock symbol
RVMD
Transactions as of
Sep 1, 2023
Transactions value $
-$1,378,809
Form type
4
Date filed
9/6/2023, 08:05 PM
Previous filing
Mar 3, 2023
Next filing
Sep 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Options Exercise $9.72K +18K +5.03% $0.54* 375K Sep 1, 2023 Direct F1, F2, F3
transaction RVMD Common Stock Options Exercise $13.4K +12K +3.2% $1.12* 387K Sep 1, 2023 Direct F1, F2, F3
transaction RVMD Common Stock Sale -$1.05M -30K -7.74% $35.05 357K Sep 1, 2023 Direct F1, F2, F3, F4
transaction RVMD Common Stock Sale -$175K -5K -12.37% $35.04 35.4K Sep 1, 2023 Trust F5, F6, F7
transaction RVMD Common Stock Sale -$175K -5K -12.37% $35.04 35.4K Sep 1, 2023 Trust F8, F9, F10
holding RVMD Common Stock 328K Sep 1, 2023 Trust F11

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -18K -8.05% $0.00 206K Sep 1, 2023 Common Stock 18K $0.54 Direct F1
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -12K -20.53% $0.00 46.5K Sep 1, 2023 Common Stock 12K $1.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on November 22, 2022.
F2 Includes 190,000 restricted stock units.
F3 Includes 1,514 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2023.
F4 This transaction was executed in multiple trades at prices ranging from $35.00 to $35.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 Transaction made pursuant to a 10b5-1 trading plan adopted by the Jonathan Henry Goldsmith Trust on November 21, 2022.
F6 This transaction was executed in multiple trades at prices ranging from $35.00 to $35.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7 Held by Jonathan Henry Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
F8 Transaction made pursuant to a 10b5-1 trading plan adopted by the Rebecca Eve Goldsmith Trust on November 21, 2022.
F9 This transaction was executed in multiple trades at prices ranging from $35.00 to $35.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F10 Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
F11 Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.

Remarks:

President and Chief Executive Officer